Expression of a functional CD3-Ti antigen/MHC receptor in the absence of surface CD2. Analysis with clonal Jurkat cell mutants

doi:10.1084/jem.168.6.2077

This Article

	Full Text (PDF, 1090K)
	Alert me when this article is cited

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Moingeon, P.
	Articles by Reinherz, E. L.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Moingeon, P.
	Articles by Reinherz, E. L.


Social Bookmarking

	What's this?

ARTICLES

Expression of a functional CD3-Ti antigen/MHC receptor in the absence of surface CD2. Analysis with clonal Jurkat cell mutants

P Moingeon, A Alcover, LK Clayton, HC Chang, C Transy and EL Reinherz
Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts.

To investigate the requirement for CD2 expression in activation of T lymphocytes via the CD3-Ti antigen/MHC receptor complex, we produced and characterized a series of CD2- Jurkat variants. These mutants lack detectable surface CD2 as determined by indirect immunofluorescence, immunoprecipitation analysis, and specific radiolabeled antibody binding assay, but nevertheless, expressed normal numbers of CD3-Ti receptors. As expected, the combination of anti-CD2 antibodies, termed anti-T112 and anti-T113, which are mitogenic for resting T lymphocytes, failed to stimulate activation of these variants. In contrast, triggering of their CD3-Ti components resulted in the normal set of T lymphocyte-associated activation events, including phosphoinositide turnover, elevation in intracellular free calcium, early gene-induction events, and IL-2 production. Assuming that the Jurkat cell line is representative of normal cycling human T lymphocytes, we conclude that the presence of the CD2 molecule on the plasma membrane is not in itself a requirement for an operational CD3-Ti-alpha/beta receptor.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Law, C.-L., Hayden-Ledbetter, M., Buckwalter, S., McNeill, L., Nguyen, H., Habecker, P., Thorne, B. A., Dua, R., Ledbetter, J. A. (2002). Expression and characterization of recombinant soluble human CD3 molecules: presentation of antigenic epitopes defined on the native TCR-CD3 complex. Int Immunol 14: 389-400 [Abstract] [Full Text]
Reinherz, E.L., Chang, H.-C., Clayton, L.K., Gardner, P., Howard, F.D., Koyasu, S., Jin, Y.-J., Moingeon, P., Sayre, P.H. (1989). The Biology of Human CD2. Cold Spring Harb Symp Quant Biol 54: 611-625 [Abstract]